Glucocorticoids regulate natural killer cell function epigenetically

Cellular Immunology

Volumn 290, Issue 1, 2014, Pages 120-130

  Eddy, Justin L ^a   Krukowski, Karen ^a   Janusek, Linda ^b   Mathews, Herbert L ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Epigenetic; Glucocorticoids; Granule constituents; Natural killer cells; Proinflammatory cytokines

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; GLUCOCORTICOID; GRANZYME B; HISTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 6; PERFORIN; PROTEIN C JUN;

ARTICLE; CELL FUNCTION; CHROMATIN; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; ENHANCER REGION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION;

EPIGENETIC; GLUCOCORTICOIDS; GRANULE CONSTITUENTS; NATURAL KILLER CELLS; PROINFLAMMATORY CYTOKINES;

ACETYLATION; CELL LINE, TUMOR; CHROMATIN; EPIGENESIS, GENETIC; GLUCOCORTICOIDS; GRANZYMES; HISTONES; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-6; KILLER CELLS, NATURAL; PERFORIN; PORE FORMING CYTOTOXIC PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, CYTOKINE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTOR RELA;

EID: 84903389041     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.05.013     Document Type: Article

References (95)

1. Lannan E.A., Galliher-Beckley A.J., Scoltock A.B., Cidlowski J.A. Proinflammatory actions of glucocorticoids: glucocorticoids and TNFalpha coregulate gene expression in vitro and in vivo. Endocrinology 2012, 153:3701-3712.
2. Miranda T.B., Morris S.A., Hager G.L. Complex genomic interactions in the dynamic regulation of transcription by the glucocorticoid receptor. Mol. Cell. Endocrinol. 2013, 380:16-24.
3. Revollo J.R., Oakley R.H., Lu N.Z., Kadmiel M., Gandhavadi M., Cidlowski J.A. HES1 is a master regulator of glucocorticoid receptor-dependent gene expression. Sci. Signal 2013, 6:ra103.
4. Biondi M. Effects of stress on immune functions: an overview. Psychoneuroimmunology 2001, 189-226. Academic Press, New York. R. Ader, N. Cohen (Eds.).
5. Holbrook N.J., Cox W.I., Horner H.C. Direct suppression of natural killer activity in human peripheral blood leukocyte cultures by glucocorticoids and its modulation by interferon. Cancer Res. 1983, 43:4019-4025.
6. Arima M., Plitt J., Stellato C., Bickel C., Motojima S., Makino S., Fukuda T., Schleimer R.P. Expression of interleukin-16 by human epithelial cells. Inhibition by dexamethasone. Am. J. Respir. Cell Mol. Biol. 1999, 21:684-692.
7. Elenkov I.J., Papanicolaou D.A., Wilder R.L., Chrousos G.P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc. Assoc. Am. Physicians 1996, 108:374-381.
8. Haynesworth S.E., Baber M.A., Caplan A.I. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J. Cell. Physiol. 1996, 166:585-592.
9. Snyers L., De Wit L., Content J. Glucocorticoid up-regulation of high-affinity interleukin 6 receptors on human epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:2838-2842.
10. Strickland R.W., Wahl L.M., Finbloom D.S. Corticosteroids enhance the binding of recombinant interferon-gamma to cultured human monocytes. J. Immunol. 1986, 137:1577-1580.
11. Yeager M.P., Pioli P.A., Wardwell K., Beach M.L., Martel P., Lee H.K., Rassias A.J., Guyre P.M. In vivo exposure to high or low cortisol has biphasic effects on inflammatory response pathways of human monocytes. Anesth. Analg. 2008, 107:1726-1734.
12. Kiecolt-Glaser J.K., Glaser R., Shuttleworth E.C., Dyer C.S., Ogrocki P., Speicher C.E. Chronic stress and immunity in family caregivers of Alzheimer's disease victims. Psychosom. Med. 1987, 49:523-535.
13. Barber A., Illner H., Shires G.T. Bacterial translocation in burn injury. Semin. Nephrol. 1993, 13:416-419.
14. Calandra T., Bucala R. Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system. Crit. Rev. Immunol. 1997, 17:77-88.
15. Lim H.Y., Muller N., Herold M.J., van den Brandt J., Reichardt H.M. Glucocorticoids exert opposing effects on macrophage function dependent on their concentration. Immunology 2007, 122:47-53.
16. Warren M.K., Vogel S.N. Opposing effects of glucocorticoids on interferon-gamma-induced murine macrophage Fc receptor and Ia antigen expression. J. Immunol. 1985, 134:2462-2469.
17. Bosch J.A., Berntson G.G., Cacioppo J.T., Marucha P.T. Differential mobilization of functionally distinct natural killer subsets during acute psychologic stress. Psychosom. Med. 2005, 67:366-375.
18. Witek-Janusek L., Albuquerque K., Chroniak K.R., Chroniak C., Durazo-Arvizu R., Mathews H.L. Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav. Immun. 2008, 22:969-981.
19. Witek-Janusek L., Gabram S., Mathews H.L. Psychologic stress, reduced NK cell activity, and cytokine dysregulation in women experiencing diagnostic breast biopsy. Psychoneuroendocrinology 2007, 32:22-35.
20. Frank M.G., Miguel Z.D., Watkins L.R., Maier S.F. Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide. Brain Behav. Immun. 2010, 24:19-30.
21. Frank M.G., Watkins L.R., Maier S.F. Stress- and glucocorticoid-induced priming of neuroinflammatory responses: potential mechanisms of stress-induced vulnerability to drugs of abuse. Brain Behav. Immun. 2011, 25(Suppl 1):S21-S28.
22. Loram L.C., Taylor F.R., Strand K.A., Frank M.G., Sholar P., Harrison J.A., Maier S.F., Watkins L.R. Prior exposure to glucocorticoids potentiates lipopolysaccharide induced mechanical allodynia and spinal neuroinflammation. Brain Behav. Immun. 2011, 25:1408-1415.
23. Sapolsky R.M. Glucocorticoids, stress, and their adverse neurological effects: relevance to aging. Exp. Gerontol. 1999, 34:721-732.
24. Sorrells S.F., Sapolsky R.M. An inflammatory review of glucocorticoid actions in the CNS. Brain Behav. Immun. 2007, 21:259-272.
25. Grayson J., Dooley N.J., Koski I.R., Blaese R.M. Immunoglobulin production induced in vitro by glucocorticoid hormones: T cell-dependent stimulation of immunoglobulin production without B cell proliferation in cultures of human peripheral blood lymphocytes. J. Clin. Invest. 1981, 68:1539-1547.
26. Plaut M. Lymphocyte hormone receptors. Annu. Rev. Immunol. 1987, 5:621-669.
27. Wiegers G.J., Knoflach M., Bock G., Niederegger H., Dietrich H., Falus A., Boyd R., Wick G. CD4(+)CD8(+)TCR(low) thymocytes express low levels of glucocorticoid receptors while being sensitive to glucocorticoid-induced apoptosis. Eur. J. Immunol. 2001, 31:2293-2301.
28. Gutsol A.A., Sokhonevich N.A., Seledtsov V.I., Litvinova L.S. Dexamethasone effects on activation and proliferation of immune memory T cells. Bull. Exp. Biol. Med. 2013, 155:474-476.
29. Baumann H., Gauldie J. The acute phase response. Immunol. Today 1994, 15:74-80.
30. Wiegers G.J., Reul J.M. Induction of cytokine receptors by glucocorticoids: functional and pathological significance. Trends Pharmacol. Sci. 1998, 19:317-321.
31. Guyre C.A., Gomes D., Smith K.A., Kaplan J.M., Perricone M.A. Development of an in vivo antibody-mediated killing (IVAK) model, a flow cytometric method to rapidly evaluate therapeutic antibodies. J. Immunol. Methods 2008, 333:51-60.
32. Sapolsky R.M., Romero L.M., Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 2000, 21:55-89.
33. Dhabhar F.S. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection versus immunopathology. Allergy Asthma Clin. Immunol. 2008, 4:2-11.
34. Dhabhar F.S. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. NeuroImmunoModulation 2009, 16:300-317.
35. Dhabhar F.S., McEwen B.S. Bi-directional effects of stress on immune function: possible explanations for salubrious as well as harmful effects, psychoneuroimmunology 2007, 723-760. Elsevier Academic Press, Burlington, MA.
36. Eastman H.B., Fawcett T.W., Udelsman R., Holbrook N.J. Effects of perturbations of the hypothalamic-pituitary-adrenal axis on the acute phase response: altered C/EBP and acute phase response gene expression in lipopolysaccharide-treated rats. Shock 1996, 6:286-292.
37. Dhabhar F.S., McEwen B.S. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:1059-1064.
38. Matsusue S., Walser M. Healing of intestinal anastomoses in adrenalectomized rats given corticosterone. Am. J. Physiol. 1992, 263:R164-R168.
39. Lekander M., Axen J., Knutsson U., Olgart Hoglund C., Werner S., Wikstrom A.C., Stierna P. Cytokine inhibition after glucocorticoid exposure in healthy men with low versus high basal cortisol levels. NeuroImmunoModulation 2009, 16:245-250.
40. Yeager M.P., Rassias A.J., Pioli P.A., Beach M.L., Wardwell K., Collins J.E., Lee H.K., Guyre P.M. Pretreatment with stress cortisol enhances the human systemic inflammatory response to bacterial endotoxin. Crit. Care Med. 2009, 37:2727-2732.
41. Cole S.W. Social regulation of leukocyte homeostasis: the role of glucocorticoid sensitivity. Brain Behav. Immun. 2008, 22:1049-1055.
42. Miller G.E., Chen E., Sze J., Marin T., Arevalo J.M., Doll R., Ma R., Cole S.W. A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biol. Psychiatry 2008, 64:266-272.
43. Miller G.E., Cohen S., Ritchey A.K. Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol. 2002, 21:531-541.
44. Bower J.E., Ganz P.A., Irwin M.R., Arevalo J.M., Cole S.W. Fatigue and gene expression in human leukocytes: increased NF-kappaB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain Behav. Immun. 2011, 25:147-150.
45. Miller A.H. Inflammation versus glucocorticoids as purveyors of pathology during stress: have we reached the tipping point?. Biol. Psychiatry 2008, 64:263-265.
46. Schmidt S., Rainer J., Ploner C., Presul E., Riml S., Kofler R. Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ. 2004, 11(Suppl. 1):S45-S55.
47. Chan H.W., Miller J.S., Moore M.B., Lutz C.T. Epigenetic control of highly homologous killer Ig-like receptor gene alleles. J. Immunol. 2005, 175:5966-5974.
48. Cippitelli M., Sica A., Viggiano V., Ye J., Ghosh P., Birrer M.J., Young H.A. Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun. J. Biol. Chem. 1995, 270:12548-12556.
49. Santourlidis S., Trompeter H.I., Weinhold S., Eisermann B., Meyer K.L., Wernet P., Uhrberg M. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J. Immunol. 2002, 169:4253-4261.
50. Krukowski K., Eddy J., Kosik K.L., Konley T., Janusek L.W., Mathews H.L. Glucocorticoid dysregulation of natural killer cell function through epigenetic modification. Brain Behav. Immun. 2011, 25:239-249.
51. Bush K.A., Krukowski K., Eddy J.L., Janusek L.W., Mathews H.L. Glucocorticoid receptor mediated suppression of natural killer cell activity: identification of associated deacetylase and corepressor molecules. Cell. Immunol. 2012, 275:80-89.
52. Burkhart B.A., Ivey M.L., Archer T.K. Long-term low level glucocorticoid exposure induces persistent repression in chromatin. Mol. Cell. Endocrinol. 2009, 298:66-75.
53. Ito K., Barnes P.J., Adcock I.M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell. Biol. 2000, 20:6891-6903.
54. Shnyreva M., Weaver W.M., Blanchette M., Taylor S.L., Tompa M., Fitzpatrick D.R., Wilson C.B. Evolutionarily conserved sequence elements that positively regulate IFN-gamma expression in T cells. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:12622-12627.
55. Hatton R.D., Harrington L.E., Luther R.J., Wakefield T., Janowski K.M., Oliver J.R., Lallone R.L., Murphy K.M., Weaver C.T. A distal conserved sequence element controls Ifng gene expression by T cells and NK cells. Immunity 2006, 25:717-729.
56. Creyghton M.P., Cheng A.W., Welstead G.G., Kooistra T., Carey B.W., Steine E.J., Hanna J., Lodato M.A., Frampton G.M., Sharp P.A., Boyer L.A., Young R.A., Jaenisch R. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 2010, 107:21931-21936.
57. Hezroni H., Sailaja B.S., Meshorer E. Pluripotency-related, valproic acid (VPA)-induced genome-wide histone H3 lysine 9 (H3K9) acetylation patterns in embryonic stem cells. J. Biol. Chem. 2011, 286:35977-35988.
58. Hezroni H., Tzchori I., Davidi A., Mattout A., Biran A., Nissim-Rafinia M., Westphal H., Meshorer E. H3K9 histone acetylation predicts pluripotency and reprogramming capacity of ES cells. Nucleus 2011, 2:300-309.
59. Adcock I.M., Barnes P.J. Molecular mechanisms of corticosteroid resistance. Chest 2008, 134:394-401.
60. Ramamoorthy S., Cidlowski J.A. Exploring the molecular mechanisms of glucocorticoid receptor action from sensitivity to resistance. Endocr. Dev. 2013, 24:41-56.
61. Spencer V.A., Davie J.R. Role of covalent modifications of histones in regulating gene expression. Gene 1999, 240:1-12.
62. Ura K., Wolffe A.P. Reconstruction of transcriptionally active and silent chromatin. Methods Enzymol. 1996, 274:257-271.
63. Northrup D.L., Zhao K. Application of ChIP-Seq and related techniques to the study of immune function. Immunity 2011, 34:830-842.
64. Izzo A., Schneider R. Chatting histone modifications in mammals. Brief. Funct. Genomics 2010, 9:429-443.
65. Oliver S.S., Denu J.M. Dynamic interplay between histone H3 modifications and protein interpreters: emerging evidence for a "histone language". ChemBioChem 2011, 12:299-307.
66. Kato S., Yokoyama A., Fujiki R. Nuclear receptor coregulators merge transcriptional coregulation with epigenetic regulation. Trends Biochem. Sci. 2011, 36:272-281.
67. Cuddapah S., Barski A., Zhao K. Epigenomics of T cell activation, differentiation, and memory. Curr. Opin. Immunol. 2010, 22:341-347.
68. Suganuma T., Workman J.L. Signals and combinatorial functions of histone modifications. Annu. Rev. Biochem. 2011, 80:473-499.
69. Bernstein B.E., Meissner A., Lander E.S. The mammalian epigenome. Cell 2007, 128:669-681.
70. Shahbazian M.D., Grunstein M. Functions of site-specific histone acetylation and deacetylation. Annu. Rev. Biochem. 2007, 76:75-100.
71. Barnes P.J., Adcock I.M. Transcription factors and asthma. Eur. Respir. J. 1998, 12:221-234.
72. Ray A., Prefontaine K.E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:752-756.
73. Truss M., Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr. Rev. 1993, 14:459-479.
74. Collado-Hidalgo A., Bower J.E., Ganz P.A., Cole S.W., Irwin M.R. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin. Cancer Res. 2006, 12:2759-2766.
75. Dantzer R., Wollman E., Vitkovic L., Yirmiya R. Cytokines and depression: fortuitous or causative association?. Mol. Psychiatry 1999, 4:328-332.
76. Glaser R., Robles T.F., Sheridan J., Malarkey W.B., Kiecolt-Glaser J.K. Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Arch. Gen. Psychiatry 2003, 60:1009-1014.
77. Johnson J.D., O'Connor K.A., Deak T., Spencer R.L., Watkins L.R., Maier S.F. Prior stressor exposure primes the HPA axis. Psychoneuroendocrinology 2002, 27:353-365.
78. Johnson J.D., O'Connor K.A., Deak T., Stark M., Watkins L.R., Maier S.F. Prior stressor exposure sensitizes LPS-induced cytokine production. Brain Behav. Immun. 2002, 16:461-476.
79. Maes M., Ombelet W., De Jongh R., Kenis G., Bosmans E. The inflammatory response following delivery is amplified in women who previously suffered from major depression, suggesting that major depression is accompanied by a sensitization of the inflammatory response system. J. Affect. Disord. 2001, 63:85-92.
80. Frank M.G., Baratta M.V., Sprunger D.B., Watkins L.R., Maier S.F. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav. Immun. 2007, 21:47-59.
81. Johnson J.D., O'Connor K.A., Hansen M.K., Watkins L.R., Maier S.F. Effects of prior stress on LPS-induced cytokine and sickness responses. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284:R422-R432.
82. Espinosa-Oliva A.M., de Pablos R.M., Villaran R.F., Arguelles S., Venero J.L., Machado A., Cano J. Stress is critical for LPS-induced activation of microglia and damage in the rat hippocampus. Neurobiol. Aging 2011, 32:85-102.
83. Munhoz C.D., Lepsch L.B., Kawamoto E.M., Malta M.B., Lima Lde S., Avellar M.C., Sapolsky R.M., Scavone C. Chronic unpredictable stress exacerbates lipopolysaccharide-induced activation of nuclear factor-kappaB in the frontal cortex and hippocampus via glucocorticoid secretion. J. Neurosci. 2006, 26:3813-3820.
84. Glaser R., Kiecolt-Glaser J.K. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol. 2005, 5:243-251.
85. Gouin J.P., Glaser R., Malarkey W.B., Beversdorf D., Kiecolt-Glaser J. Chronic stress, daily stressors, and circulating inflammatory markers. Health Psychol. 2012, 31:264-268.
86. Segerstrom S.C., Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30years of inquiry. Psychol. Bull. 2004, 130:601-630.
87. Irwin M.R., Miller A.H. Depressive disorders and immunity: 20years of progress and discovery. Brain Behav. Immun. 2007, 21:374-383.
88. Kronfol Z., House J.D., Silva J., Greden J., Carroll B.J. Depression, urinary free cortisol excretion and lymphocyte function. Br. J. Psychiatry 1986, 148:70-73.
89. Maes M., Bosmans E., Suy E., Minner B., Raus J. A further exploration of the relationships between immune parameters and the HPA-axis activity in depressed patients. Psychol. Med. 1991, 21:313-320.
90. Miller A.H., Asnis G.M., Lackner C., Halbreich U., Norin A.J. Depression, natural killer cell activity, and cortisol secretion. Biol. Psychiatry 1991, 29:878-886.
91. Miller G.E., Cohen S., Herbert T.B. Pathways linking major depression and immunity in ambulatory female patients. Psychosom. Med. 1999, 61:850-860.
92. Pike J.L., Irwin M.R. Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder. Brain Behav. Immun. 2006, 20:169-174.
93. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., McCorkle R., Seligman D.A., Schmidt K. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav. Immun. 2001, 15:199-226.
94. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 2009, 71:171-186.
95. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctot K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.